![]() |
Volumn 371, Issue 11, 2014, Pages e15-
|
PARADIGM-HF - The experts' discussion
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ENALAPRIL;
ENKEPHALINASE INHIBITOR;
3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONATE 3' METHYL 2' (PENTANOYL(2' (TETRAZOL 5 YLATE)BIPHENYL 4' YLMETHYL)AMINO)BUTYRATE;
3-(1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-3'-METHYL-2'-(PENTANOYL(2'-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE;
AMINOBUTYRIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
MEMBRANE METALLOENDOPEPTIDASE;
TETRAZOLE DERIVATIVE;
HEART FAILURE;
PRIORITY JOURNAL;
SHORT SURVEY;
SOCIAL MEDIA;
ARTICLE;
DRUG ANTAGONISM;
DRUG COMBINATION;
HEART STROKE VOLUME;
HUMAN;
AMINOBUTYRATES;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DRUG COMBINATIONS;
ENALAPRIL;
HEART FAILURE;
HUMANS;
NEPRILYSIN;
STROKE VOLUME;
TETRAZOLES;
|
EID: 84907050445
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1410203 Document Type: Article |
Times cited : (15)
|
References (0)
|